South Korean biopharmaceutical company Celltrion has announced plans to burn around 1.1 million of its own shares to increase shareholder value. This represents about 11% of the total shares held and 0.5% of the total issued shares, worth approximately KRW 203.3 billion. The move follows a series of shareholder-friendly policies, including recent acquisitions of its own shares and dividend expansion. The shares will be burned on March 25, and all shares purchased this year will also be burned.
Original Article: Read More
Auto-posted at: 2025-03-14 10:55:33